Sign in

CIK 0001783183

  • Non-accelerated filer
  • Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
824151574
Phone
+1 877-742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-10 Basta Steven L President and CEO Grant or award +12,362 379,592
2026-02-10 Basta Steven L President and CEO Shares withheld for taxes −6,277 $12.82 $80K 373,315
2026-01-02 Basta Steven L President and CEO Grant or award +251,034 364,820
2026-01-02 Basta Steven L President and CEO Grant or award · Stock Option (Right to Buy) +226,156 221,156
2025-12-17 Basta Steven L President and CEO Grant or award +62,038 145,288
2025-12-17 Basta Steven L President and CEO Shares withheld for taxes −31,502 $15.36 $484K 113,786
2025-11-28 Basta Steven L President and CEO Option exercise +90,000 131,625
2025-11-28 Basta Steven L President and CEO Shares withheld for taxes −48,375 $15.62 $756K 83,250
2025-11-28 Basta Steven L President and CEO Option exercise · Performance Shares −90,000 180,000
2025-09-25 Basta Steven L President and CEO Option exercise +90,000 90,000
2025-09-25 Basta Steven L President and CEO Shares withheld for taxes −48,375 $11.66 $564K 41,625
2025-09-25 Basta Steven L President and CEO Option exercise · Performance Shares −90,000 270,000
2025-04-03 Basta Steven L President and CEO Grant or award · Performance Shares +360,000 360,000
2025-04-03 Basta Steven L President and CEO Grant or award · Stock Option (Right to Buy) +1,085,000 1,085,000

Page 1 of 1 · 14 trades